Hyperion Defi (HYPD) Preferred Shares (2016 - 2026)

Hyperion Defi (HYPD) posted quarterly Preferred Shares of $524.0 for Q1 2026, down 3.68% quarter-over-quarter from $544.0 in Q4 2025.

Hyperion Defi (HYPD) Preferred Shares (2016 - 2026) Analysis & Trends

Hyperion Defi (HYPD) has reported Preferred Shares for 4 consecutive years, with $524.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Preferred Shares changed N/A year-over-year to $524.0; the TTM figure through Mar 2026 stood at $524.0 (changed N/A YoY), while the FY2025 annual figure was $544.0, changed N/A from the prior year.
Preferred Shares eased to $524.0 in Q1 2026 per HYPD's latest filing, from $544.0 in the prior quarter.
Across five years, Preferred Shares topped out at $544.0 in Q2 2025 and bottomed at $524.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.71 Bn	131.86 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.87 Bn	78.87 Bn	3.93 Bn	-
3	Argenx Se	65.40 Bn	60.22 Bn	1.37 Bn	-
4	Moderna	59.36 Bn	54.22 Bn	52.00 Mn	-
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.91 Bn	28.60 Bn	992.69 Mn	-
7	BioNTech SE	28.17 Bn	9.78 Bn	668.28 Mn	-
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	-
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	Hyperion Defi	46.06 Mn	36.43 Mn	357,693.00	524.00

Download Data